Related Experiment Video
Updated: Sep 15, 2025

Deep Dermal Injection As a Model of Candida albicans Skin Infection for Histological Analyses
Published on: June 13, 2018
Cutaneous Mucormycosis in a Patient With Cirrhosis: A Case Report
Haley Belt1, Margaret Kypreos1, An Lu1
1Division of Pulmonary and Critical Care Medicine, University of Texas Southwestern Medical Center, Dallas, USA.
Abstract:
The global incidence of invasive mucormycosis (mucor) infection is on the rise due in part to an increased utilization of immunosuppressive therapies to treat malignancies and autoimmune diseases. While cirrhosis has previously been considered a risk factor for fungal infections, very little is known about the inciting factors precipitating development of isolated cutaneous mucormycosis infection. This form of mucor poses a significant mortality risk despite antifungal and surgical treatments and has been documented in only 5 patients with cirrhosis prior to our case report. This case report presents the sixth documented case of cutaneous mucormycosis in a patient with cirrhosis and explore nosocomial etiologies for its progression to clinically significant infection.
Insights
Global mucormycosis infections are increasing. This case report details the sixth instance of cutaneous mucormycosis in a cirrhosis patient, exploring potential nosocomial causes for this severe fungal infection.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Hepatology
Background:
- Invasive mucormycosis (mucor) incidence is rising globally, linked to increased immunosuppressive therapies for cancer and autoimmune conditions.
- Cirrhosis is a known risk factor for fungal infections, yet inciting factors for isolated cutaneous mucormycosis remain poorly understood.
- Cutaneous mucormycosis carries a high mortality risk and is rarely documented in cirrhosis patients (only 5 cases prior to this report).
Purpose of the Study:
- To present the sixth documented case of cutaneous mucormycosis in a patient with cirrhosis.
- To investigate potential nosocomial etiologies contributing to the development of clinically significant cutaneous mucormycosis in this patient population.
Main Methods:
- Case report presentation.
- Review of patient history and clinical course.
- Exploration of potential nosocomial exposures and risk factors.
Main Results:
- This report details the sixth case of cutaneous mucormycosis in a patient with cirrhosis.
- The study explores potential nosocomial factors that may have precipitated the infection's progression.
Conclusions:
- Cutaneous mucormycosis is a rare but severe complication in cirrhosis patients.
- Further investigation into nosocomial factors is crucial for understanding and preventing mucormycosis in immunocompromised individuals with liver disease.
Related Concept Videos
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Fungal Phylum Microsporidia
Fungal Group Zygomycota

